Corey Goodman Net Worth & Insider Trades
Corey Goodman Akero Therapeutics, Inc
What is Corey Goodman's Net Worth?
The current estimated net worth of Akero Therapeutics, Inc's Corey Goodman is estimated to be about $421.13M . Corey Goodman owns about 3,033,552 units of Akero Therapeutics, Inc common stock. In the last year at Akero Therapeutics, Inc, Corey Goodman has sold an estimated value of $21.09M worth.
What is Corey Goodman's Past Insider Trading?
Corey Goodman's largest purchase order was 3,954,858 units , worth over $4M on June 25, 2019. Corey Goodman's largest sale order was 494,000 units , worth over $9.99M on January 14, 2020. In total, Corey Goodman has made about 13 transactions over a year of their time at Akero Therapeutics, Inc. Corey Goodman usually trades in January, with the busiest year in 2020. The most recent transaction was a sale order of 116,467 units , worth over $4.01M on July 6, 2020.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
venBio Global Strategic Fund II LP, venBio Global Strategic GP II LP, venBio Global Strategic GP II Ltd, Robert Adelman, COREY GOODMAN
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Corey Goodman's' Mailing Address?
- Mailing address is 1700 Owens Street Suite 595 San Francisco CA 94158 CA
What are Akero Therapeutics, Inc's Past Insider Trades?
Akero Therapeutics, Inc's most recent insider trade came on December 5, 2023 by Walmsley Graham who bought 100,000 units worth $1.69M . In the last 4 years, insiders at Akero Therapeutics, Inc have sold an estimated value of $169.89M and bought an estimated value of $107M worth of shares. Insider trading is most common in June, with the busiest year in 2023 and 2022. The most active traders at the company are Andrew Cheng, President and CEO, Jonathan Young, Chief Operating Officer, and William White, Chief Financial Officer .
Akero Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |